JPRN-UMIN000051390招募中Unknown
Investigation of the effect of long-acting diquafosol sodium ophthalmic solution on the ocular surface and its usability - Investigation of the effect of long-acting diquafosol sodium ophthalmic solution
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •the presence of ocular surgery and trauma within the last 6 months, permanent structural damage due to ocular trauma, receiving pressure-lowering agents for the treatment of glaucoma and current contact lens
研究者
相似试验
进行中（未招募）
不适用
Follow on study from RE-ALIGAnticoagulation following mechanical heart valve surgeryMedDRA version: 14.0Level: PTClassification code 10053468Term: Anticoagulant therapySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-002285-21-CZBoehringer Ingelheim RCV GmbH & Co KG405
进行中（未招募）
不适用
A long term follow on study from RE-ALIGN to evaluate safety of dabigatran etexilate in patients with mechanical heart valve.Anticoagulation following mechanical heart valve surgeryMedDRA version: 14.0Level: PTClassification code 10053468Term: Anticoagulant therapySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-002285-21-DKBoehringer Ingelheim Ltd405
进行中（未招募）
不适用
Follow on study from RE-ALIGAnticoagulation following mechanical heart valve surgeryMedDRA version: 15.0Level: PTClassification code 10053468Term: Anticoagulant therapySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-002285-21-DEBoehringer Ingelheim Pharma GmbH & Co.KG405
进行中（未招募）
1 期
Follow on study from RE-ALIGAnticoagulation following mechanical heart valve surgeryMedDRA version: 14.1Level: PTClassification code 10053468Term: Anticoagulant therapySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-002285-21-BESCS Boehringer Ingelheim Comm.V405
尚未招募
3 期
D-004 in patients with Bening Prostatic HyperplasiaBenign Prostatic HyperplasiaRPCEC00000138atural Products Center (CPN)100